
HCA Healthcare, Inc. (HCA) Presents at TD Cowen 46th Annual Health Care Conference Transcript
HCA Healthcare, Inc. (HCA) Presents at TD Cowen 46th Annual Health Care Conference Transcript
Loading news...

HCA Healthcare, Inc. (HCA) Presents at TD Cowen 46th Annual Health Care Conference Transcript

Elo Mutual Pension Insurance Co grew its holdings in shares of HCA Healthcare, Inc. (NYSE: HCA) by 19.2% in the undefined quarter, according to its most recent disclosure with the SEC. The fund owned 14,594 shares of the company's stock after purchasing an additional 2,351 shares during the period. Elo Mutual Pension Insurance

NASHVILLE, Tenn.--(BUSINESS WIRE)--HCA Healthcare, Inc. (NYSE: HCA) is scheduled to present at the following healthcare conferences: March 3, 2026 at 10:30am ET at the TD Cowen Health Care Conference March 4, 2026 at 9:50am ET at the Raymond James Institutional Investors Conference March 10, 2026 at 10:00am ET at the Leerink Partners Global Healthcare Conference March 10, 2026 at 2:00pm ET at the Barclays Global Healthcare Conference March 16, 2026 at 3:20pm ET at the Oppenheimer MedTech &.

HCA (HCA) reported earnings 30 days ago. What's next for the stock?

NASHVILLE, Tenn.--(BUSINESS WIRE)--HCA Healthcare, Inc. (NYSE:HCA), one of the nation's leading healthcare providers, today announced that it has been named on Fortune's 2026 World's Most Admired Companies list. HCA Healthcare is ranked No. 1 in its industry again this year. “We are proud to again be recognized on Fortune's World's Most Admired Companies list,” said Sam Hazen, CEO of HCA Healthcare. “I am grateful to our colleagues for the way they lead with compassion and the high standards th.

Finding strong, market-beating stocks with a positive earnings outlook becomes easier with the Focus List, a top feature of the Zacks Premium portfolio service.

Chase Investment Counsel Corp reduced its holdings in shares of HCA Healthcare, Inc. (NYSE: HCA) by 69.3% during the undefined quarter, according to its most recent 13F filing with the SEC. The fund owned 4,926 shares of the company's stock after selling 11,100 shares during the period. Chase Investment Counsel Corp's holdings in

First Eagle Global Real Assets Fund Q4 2025 Portfolio Review

The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.

HCA Healthcare, Inc. (NYSE: HCA - Get Free Report) EVP Michael Mcalevey sold 1,694 shares of the company's stock in a transaction dated Wednesday, February 18th. The shares were sold at an average price of $533.37, for a total transaction of $903,528.78. Following the completion of the transaction, the executive vice president directly owned 8,853 shares

The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.

Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.

HCA Healthcare, Inc. (NYSE: HCA - Get Free Report) SVP Christopher Wyatt sold 4,000 shares of the firm's stock in a transaction dated Wednesday, February 11th. The shares were sold at an average price of $505.00, for a total value of $2,020,000.00. Following the sale, the senior vice president directly owned 44,379 shares in the company,

Cherokee Insurance Co reduced its position in shares of HCA Healthcare, Inc. (NYSE: HCA) by 19.8% during the undefined quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 8,100 shares of the company's stock after selling 2,000 shares during the quarter.

HCA Healthcare reported strong financial results and encouraging guidance. The medical facilities operator has important long-term growth opportunities.

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Focus List.

Shares of HCA Healthcare, Inc. (NYSE: HCA - Get Free Report) have been given an average rating of "Moderate Buy" by the twenty-five analysts that are presently covering the firm, Marketbeat Ratings reports. One analyst has rated the stock with a sell recommendation, eight have issued a hold recommendation and sixteen have issued a buy recommendation

The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.

Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Focus List.